The 20 Best Familial Prostate Cancer Doctors Near Me in Teaneck, NJ

Vincent Lanteri is a Urologist practicing medicine in Teaneck, New Jersey. Dr. Lanteri is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, Urethral Stricture, Ureteroscopy, and Bladder Reconstruction. Dr. Lanteri is board certified in American Board Of Urology.

Glen Gejerman is a Radiation Oncologist practicing medicine in Hackensack, New Jersey. Dr. Gejerman is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer. Dr. Gejerman is board certified in American Board Of Radiology.

Robert Alter is an Otolaryngologist practicing medicine in Hackensack, New Jersey. Dr. Alter is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Urothelial Cancer, Endoscopy, and Nephrectomy.

Ravi Munver is a Urologist practicing medicine in Hackensack, New Jersey. Dr. Munver is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Horseshoe Kidney, Prostate Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Munver is board certified in American Board Of Urology.

Andrew Jennis is an Oncologist practicing medicine in Hackensack, New Jersey. Dr. Jennis is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Familial Pancreatic Cancer, and Endoscopy. Dr. Jennis is board certified in American Board Of Internal Medicine.

Michael Stifelman is a Urologist practicing medicine in Hackensack, New Jersey. Dr. Stifelman is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), UPJ Obstruction, Retroperitoneal Fibrosis, Nephrectomy, and Ureteral Reconstruction. Dr. Stifelman is board certified in American Board Of Urology.

Thomas Christiano is a Urologist practicing medicine in Maywood, New Jersey. Dr. Christiano is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Horseshoe Kidney, Muscle Invasive Bladder Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Reconstructive Urology Surgery. Dr. Christiano is board certified in American Board Of Urology.

Mutahar Ahmed is a Urologist practicing medicine in Maywood, New Jersey. Dr. Ahmed is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Ureterocele, Nephrectomy, and Ureteral Reconstruction. Dr. Ahmed is board certified in American Board Of Urology.

Martin Goldstein is a Urologist practicing medicine in Maywood, New Jersey. Dr. Goldstein is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Perirenal Abscess, Carbuncle, and Folliculitis. Dr. Goldstein is board certified in American Board Of Urology.

Andrew Siegel is a Urologist practicing medicine in Maywood, New Jersey. Dr. Siegel is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Incontinence, Familial Prostate Cancer, and Prostate Cancer. Dr. Siegel is board certified in American Board Of Urology.

Gregory Lovallo is an Oncologist practicing medicine in Maywood, New Jersey. Dr. Lovallo is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Obstructive Uropathy, Muscle Invasive Bladder Cancer, Enlarged Prostate (BPH), Nephrectomy, and Reconstructive Urology Surgery. Dr. Lovallo is board certified in American Board Of Urology.

Michael Morris is an Oncologist practicing medicine in New York, New York. Dr. Morris is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Vocal Cord Dysfunction, Hip Replacement, and Knee Replacement. Dr. Morris is currently accepting new patients.

Dana Rathkopf is an Oncologist practicing medicine in New York, New York. Dr. Rathkopf is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Prostatectomy, and Orchiectomy. Dr. Rathkopf is currently accepting new patients.

Behfar Ehdaie is a Urologist practicing medicine in New York, New York. Dr. Ehdaie is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy. Dr. Ehdaie is currently accepting new patients.

Howard Scher is an Oncologist practicing medicine in New York, New York. Dr. Scher is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Orchiectomy, and Prostatectomy. Dr. Scher is currently accepting new patients.

Ashutosh Tewari is a Urologist practicing medicine in New York, New York. Dr. Tewari is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urinary Incontinence, Prostatectomy, and Vasectomy. Dr. Tewari is currently accepting new patients.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.

Dr. Stein is an Associate Professor of Medical Oncology at Columbia University Medical Center. He is a recognized expert in field of genitourinary oncology – treating patients with prostate, kidney, bladder and testicular cancers. He is also a member of the Experimental Therapeutics program, investigating novel therapies across all solid tumors. In addition to providing standard therapies for the treatment of genitourinary cancers such as hormonal therapy, molecularly targeted therapy and chemotherapy, Dr. Stein leads multiple investigator initiated and industry sponsored clinical trials. Dr. Stein has a particular interest in the development of novel immune therapies for the treatment of prostate cancer, both in men with early recurrence of prostate cancer as well as in men with more advanced prostate cancer. He is also helping to lead two national trials in kidney cancer sponsored by the National Cancer Institute.Dr. Stein received his B.S. in Molecular Biophysics and Biochemistry from Yale University. He earned his medical degree at New York Medical College, receiving the graduation award in oncology for his published research. He completed a residency in internal medicine at Montefiore Medical Center, and a fellowship in Hematology and Medical Oncology at Mount Sinai Medical Center. Prior to joining Columbia University, Dr. Stein practiced genitourinary oncology for 13 years at Rutgers University and has been an author on over 60 publications including guidelines for assessing the efficacy of new drugs in prostate cancer and recommendations for the use of immunotherapy to treat prostate cancer. Dr. Stein is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), and Familial Prostate Cancer. Dr. Stein is board certified in Medical Oncology. Dr. Stein is currently accepting new patients.

Israel Deutsch, M.D., is Assistant Professor of Radiation Oncology at New York-Presbyterian/Columbia University Medical Center. Dr. Deutsch cares for patients with all types of cancer, with a special interest in Prostate, Gynecologic, and Head & Neck cancers. He is Director of Brachytherapy Services in the Department of Radiation Oncology. Dr. Deutsch is a respected researcher with numerous peer-reviewed contributions to medical literature and has edited many book chapters in his areas of expertise. He is a member of the Review Committee on Continuing Medical Education at Columbia University Medical Center. Dr. Deutsch received his medical degree from Albert Einstein College of Medicine. He then received transitional year training during an internship at New York Hospital Queens, after which he completed his radiation oncology residency at SUNY Downstate Medical Center. Dr. Deutsch then furthered his training with a fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center. In collaboration with several clinical and basic science colleagues, he is conducting a number of clinical and translational studies. Dr. Deutsch sits on the Internal Review Board (IRB) for Clinical Trials and is also a member of the Children’s Oncology Group (COG) as Investigator representing the Department of Radiation Oncology. Dr. Deutsch is very involved in residency education and serves as Associate Director of the Radiation Oncology Residency Program at New York Presbyterian/Columbia University Medical Center. Dr. Deutsch is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Melanoma of the Eye, and Endometrial Cancer. Dr. Deutsch is board certified in Radiation Oncology. Dr. Deutsch is currently accepting new patients.

An internationally renowned expert in prostate cancer treatment and radiation oncology pioneer, Louis Potters, MD, FASTRO, FABS, FACR serves as Senior Vice President and Deputy Physician-in-Chief of the Northwell Cancer Institute while chairing its Department of Radiation Medicine. His contributions span clinical excellence, research innovation, and healthcare policy development. As a key architect of national cancer treatment guidelines and advisor to the US Nuclear Regulatory Commission, Dr. Potters has helped shape modern radiation oncology standards and safety protocols.His distinguished service includes positions on the Commission on Cancer executive committee, National Quality Forum panels, and multiple Health and Human Services committees, where he has been instrumental in advancing healthcare quality nationwide. As senior editor of Practical Radiation Oncology and editorial board member for leading journals including Oncology and Brachytherapy, he continues to guide professional discourse and scientific advancement in the field. A member of the prestigious Alpha Omega Alpha honor society, Dr. Potters has demonstrated exceptional commitment to medical excellence throughout his career. He recognized year over year in a number of Best Doctor awards by Castle Connolly, is featured in New York Magazine and as a NY Times SuperDoc.Throughout his 32-year clinical practice treating thousands of prostate cancer patients, Dr. Potters has pioneered innovative approaches to patient care and quality assurance. His leadership of one of the nation's largest radiation oncology departments has fostered excellence in patient care, groundbreaking research, and comprehensive medical education. The Smarter Radiation Oncology program he developed has gained international recognition for setting new standards in quality metrics, safety protocols, and patient experience. His academic contributions include over 200 peer-reviewed publications that have significantly advanced the field of radiation oncology and prostate cancer treatment.Under his guidance, the Northwell Health Department of Radiation Medicine has become a leading force in implementing cutting-edge treatments while training the next generation of oncology leaders. Dr. Potters continues to drive innovation in personalized cancer care, process improvement, and clinical outcomes, maintaining Northwell's position at the forefront of modern oncology practice. Dr. Potters is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Potters is board certified in American Board Of Internal Medicine and American Board Of Radiology/Radiation Oncology.